✕ CLOSE Online Special City News Entrepreneurship Environment Factcheck Everything Woman Home Front Islamic Forum Life Xtra Property Travel & Leisure Viewpoint Vox Pop Women In Business Art and Ideas Bookshelf Labour Law Letters
Click Here To Listen To Trust Radio Live
SPONSOR AD

Court adjourns ruling in Pfizer case to Oct 27

The case was originally brought by Mustapha Maisikeli against Pfizer and the Board of Trustees of the Healthcare/Meningitis Trust Fund whose cases against the company…

The case was originally brought by Mustapha Maisikeli against Pfizer and the Board of Trustees of the Healthcare/Meningitis Trust Fund whose cases against the company were purportedly settled mutually and dismissed about three years ago.
At the resumed hearing yesterday, Pfizer through its lawyer, Chief Anthony Idigbe, had challenged the amended writ of summons and statement of claim filed on behalf of the plaintiffs.
Daily Trust recalls that Justice Banjoko had earlier ordered alteration of the parties in the suit when both agreed to discontinue the case with them.
Following the order, the plaintiff not only amended the names of the parties to the suit in other to reflect their connection to the case but also made consequential amendment touching on the statement of claim and the pleadings.
However, Pfizer told the court that the plaintiffs cannot change the fact in the middle of the argument.
Pfizer, according to Idigbe, has reconstructed and tried to restructure the facts of the case.   According to Pfizer, “this new and latest legal action before the FCT High Court, Abuja is completely groundless and prohibited by unconditional releases signed by these same plaintiffs and delivered to Pfizer as a condition of their resolution of similar past litigation.”

Join Daily Trust WhatsApp Community For Quick Access To News and Happenings Around You.

Do you need your monthly pay in US Dollars? Acquire premium domains for as low as $1500 and have it resold for as much as $17,000 (₦27 million).


Click here to see how Nigerians are making it.